Remidio, a health technology innovator developing cutting-edge technology to combat global blindness from Diabetic Retinopathy, Glaucoma, AMD and Cataracts, is all set to achieve a significant milestone.
This quarter, Remidio, is excited to be placing its 1,000th FOP-NM handheld fundus camera in the hands of US healthcare providers. Since 2019, these devices have been supporting diabetic retinopathy screening activities of over 3,500 high volume healthcare providers in the US.
Remidio’s FOP-NM is the world’s first smartphone-based non-mydriatic fundus camera, eliminating the need for patient dilation and is rapidly revolutionising retinal examinations in the US; both within clinic settings and beyond, with equal impact.
The FOP-NM is an easy to use, easy to train retinal camera that provides excellent image quality empowering medical specialists and non-specialists (nurses or any healthcare personnel) to conduct retinal exams anywhere: in the clinic, home, in emergency rooms or remote rural healthcare centres.
The portability of the device has also found widespread acceptance from university health systems as well, such as the University of Virginia, and several others.
University of Virginia’s Assistant Professor of Ophthalmology, Dr Arjun Dirghangi, said: “Remidio’s FOP-NM is easier to use, easy to train on. We have gotten good images, even from trainees who have never used the system before, within 30 seconds to two minutes per eye. My goal at the end of the day is to improve access to screening. And this is certainly one of the more powerful tools that I have seen to be able to do that.”